Neuropsychopharmacology
- Opportunities for use of neuroimaging in de-risking drug development and improving clinical outcomes in psychiatry: an industry perspective2 years ago
- A new prism next to motherhood’s light: uncovering changes in neural function following childbirth2 years ago
- Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry2 years ago
- Basal forebrain-lateral habenula inputs and control of impulsive behavior2 years ago
- Concurrent and longitudinal neurostructural correlates of irritability in children2 years ago
- Distributed circuits regulating defensive state transitions: freezing, flight and fight2 years ago
- AMPA receptors modulate enhanced dopamine neuronal activity induced by the combined administration of venlafaxine and brexpiprazole2 years ago
Journal of Psychopharmacology
- Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes4 years ago
- The influence of stimulus onset asynchrony, task order, sex and hormonal contraception on prepulse inhibition and prepulse facilitation: Methodological considerations for drug and imaging research4 years ago
- Clinical correlates of early onset antipsychotic treatment resistance4 years ago
- Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia4 years ago
- Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review4 years ago
- D2-like receptor activation by intranasal dopamine attenuates fear responses induced by electrical stimulation of the dorsal periaqueductal grey matter, but fails to reduce aversion to pit vipers and T-maze performance4 years ago
- Efficacy of aripiprazole as adjunctive therapy in major depressive disorder with somatic symptoms: A randomized, double-blind, placebo-controlled trial with clinical and electroencephalography evidence4 years ago
European Neuropsychopharmacology
- Treating major depressive disorder with mixed features3 years ago
- New biomarkers in mood disorders: Insights from immunopsychiatry and neuroimaging3 years ago
- In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior3 years ago
- Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes3 years ago
- Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study3 years ago
- Higher lymphocyte count associated with larger hippocampal volume and fewer depressive symptoms in drug–na ïve first-episode psychosis3 years ago
- Number needed to treat and number needed to harm: What are they good for?3 years ago